CLINICAL RESEARCH
Association of causes of type 2 diabetes mellitus and gestational diabetes with the clinical profile in the population of Khyber Pakhtunkhwa Pakistan
 
More details
Hide details
1
Department of Biochemistry, Abdul Wali Khan University Mardan, Pakistan
 
2
Department of Medicine and Surgery, Khyber Medical College Peshawar, Pakistan
 
 
Submission date: 2022-08-12
 
 
Final revision date: 2022-10-05
 
 
Acceptance date: 2022-10-05
 
 
Publication date: 2022-12-12
 
 
Arch Med Sci Civil Dis 2022;7(1):44-52
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The current study is designed to assess the various risk factors, prevalence, and clinical characteristics of type 2 diabetes (among aged Pakistanis) and gestational diabetes (in pregnant women).

Material and methods:
The statistical analysis of a cross-sectional survey included the data of 1479 adults, aged 18–75 years, living in urban and rural areas. Blood glucose was measured by an automatic clinical chemistry analyser. Diabetes was confirmed via an glycated hemoglobin (HbA1c) report from each patient’s file admitted in medical and surgical wards. Blood pressures were measured and recorded, and the medical history and prior illness data were collected by interviewing the patients and cross checked with their individual daily progress report.

Results:
The prevalence of type 2 diabetes mellitus in different age groups in urban and rural areas was 5.3%, among which 9.8% was found to be previously diagnosed type 2 diabetes mellitus and 7% was newly diagnosed type II diabetes, whereas the percentage of gestational diabetes was 1.36% of the total ratio (5.3%). Type 2 diabetes mellitus affected more women than men, which increased with age. Central obesity and hypertension were highly associated with type 2 diabetes mellitus occurrence. The prevalence of previously diagnosed type 2 diabetes mellitus with overweight or obesity was 68.4%, with central obesity 32.3%, and with hypertension 56.5%. A significant association (p = 0.005) was found between obesity, as a risk factor, gestational diabetes, and type 2 diabetes mellitus.

Conclusions:
These results show that diabetes has reached high proportions, and comprehensive strategies are needed for the prevention and control of the problem of type II diabetes.

REFERENCES (37)
1.
Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50.
 
2.
Yang MH, Hall SA, Piccolo RS, Maserejian NN, McKinlay JB. Do behavioral risk factors for prediabetes and insulin resistance differ across the socioeconomic gradient? Results from a community-based epidemiologic survey. Int J Endocrinol 2015; 2015: 806257.
 
3.
Adnan M, Aasim M. Prevalence of type 2 diabetes mellitus in adult population of Pakistan: a meta-analysis of prospective cross-sectional surveys. Ann Glob Health 2020; 86: 7.
 
4.
Riaz M, Nawaz A, Masood SN, Fawwad A, Basit A, Shera AS. Frequency of gestational diabetes mellitus using DIPSI criteria, a study from Pakistan. Clin Epidemiol Glob Health 2019; 7: 218-21.
 
5.
Amin N, Doupis J. Diabetic foot disease: from the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes 2016; 7: 153-64.
 
6.
Halban PA, Polonsky KS, Bowden DW, et al. -cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab 2014; 99: 1983-92.
 
7.
Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020; 21: 6275.
 
8.
Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32 (Suppl 1): S62-7.
 
9.
Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes 2015; 6: 92-108.
 
10.
Association AD. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2012; 36 (Suppl): S67-74.
 
11.
Pratley RE. The early treatment of type 2 diabetes. Am J Med 2013; 126 (9 Suppl 1): S2-9.
 
12.
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci 2018; 19: 3342.
 
13.
Hackett RA, Steptoe A. Psychosocial factors in diabetes and cardiovascular risk. Curr Cardiol Rep 2016; 18: 95.
 
14.
Kivimäki M, Virtanen M, Kawachi I, et al. Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals. Lancet Diabetes Endocrinol 2015; 3: 27-34.
 
15.
Ferrer R, Klein WM. Risk perceptions and health behavior. Curr Opin Psychol 2015; 5: 85-9.
 
16.
Association AD. Standards of medical care in diabetes--2011. Diabetes Care 2011; 34 Suppl 1: S11-61.
 
17.
Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today 2015; 50: 117-28.
 
18.
Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
 
19.
Lee EH. Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res 2012; 6: 121-7.
 
20.
Cederberg H, Laakso M. Obesity and type 2 diabetes. In: Handbook of Obesity: Epidemiology, Etiology, and Physiopathology. Third Edition 2014; 539-48.
 
21.
Zeru MA, Tesfa E, Mitiku AA, Seyoum A, Bokoro TA. Prevalence and risk factors of type-2 diabetes mellitus in Ethiopia: systematic review and meta-analysis. Sci Rep 2021; 11: 1-15.
 
22.
Herath H, Herath R, Wickremasinghe R. Gestational diabetes mellitus and risk of type 2 diabetes 10 years after the index pregnancy in Sri Lankan women – a community based retrospective cohort study. PLoS One 2017; 12: e0179647.
 
23.
Farrar D. Hyperglycemia in pregnancy: prevalence, impact, and management challenges. Int J Womens Health 2016; 8: 519-27.
 
24.
Aamir AH, Ul-Haq Z, Mahar SA, et al. Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open 2019; 9: e025300.
 
25.
Mukai N, Hata J, Hirakawa Y, et al. Trends in the prevalence of type 2 diabetes and prediabetes in a Japanese community, 1988–2012: the Hisayama Study. Int 2019; 10: 198-205.
 
26.
Min H, Chang J, Balkrishnan R. Sociodemographic risk factors of diabetes and hypertension prevalence in republic of Korea. Int J Hypertens 2010; 2010: 410794.
 
27.
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119.
 
28.
Zhang YN, He L. Risk factors study of ischemic stroke in young adults in Southwest China. Sichuan Da Xue Xue Bao Yi Xue Ban 2012; 43: 553-7.
 
29.
Ali O. Genetics of type 2 diabetes. World J Diabetes 2013; 4: 114-23.
 
30.
Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diab Rep 2014; 14: 508.
 
31.
Hilliard ME, Yi-Frazier JP, Hessler D, Butler AM, Anderson BJ, Jaser S. Stress and A1c among people with diabetes across the lifespan. Curr Diab Rep 2016; 16: 67.
 
32.
Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 2020; 10: 14790.
 
33.
McFarlane SI, Sica DA, Sowers JR. Stroke in patients with diabetes and hypertension. J Clin Hypertens 2005; 7: 284-6.
 
34.
Shrestha DB, Budhathoki P, Raut S, et al. New-onset diabetes in COVID-19 and clinical outcomes: asystematic review and meta-analysis. World J Virol 2021; 10: 275-87.
 
35.
Kgosidialwa O, Bogdanet D, Egan AM, et al. A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study. BJOG 2021; 128: 1855-68.
 
36.
Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369: m1361.
 
37.
Yaping X, Chunhong L, Huifen Z, Fengfeng H, Huibin H, Meijing Z. Risk factors associated with gestational diabetes mellitus: a retrospective case-control study. Int J Diabetes Dev Ctries 2022; 42: 91-100.
 
ISSN:2451-0637
Journals System - logo
Scroll to top